was read the article
array:22 [ "pii" => "S2529912321000218" "issn" => "25299123" "doi" => "10.1016/j.artere.2021.04.003" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "546" "copyrightAnyo" => "2021" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Clin Investig Arterioscler. 2021;33:169-74" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0214916820300851" "issn" => "02149168" "doi" => "10.1016/j.arteri.2020.07.001" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "546" "copyright" => "Sociedad Española de Arteriosclerosis" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Clin Invest Arterioscl. 2021;33:169-74" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">ORIGINAL</span>" "titulo" => "Perfil lipídico y concentraciones séricas de ácido fólico, vitamina B12 y homocisteína en pacientes con obstrucción venosa retiniana" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "169" "paginaFinal" => "174" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Lipid profile and serum folate, vitamin B<span class="elsevierStyleInf">12</span> and homocysteine levels in patients with retinal vein occlusion" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Javier Napal Lecumberri, Paula González Bores, Alicia Cuesta Marín, Francisco Alejandro Caballero Avendaño, Jose Manuel Olmos Martínez, Jose Luis Hernández Hernández" "autores" => array:6 [ 0 => array:2 [ "nombre" => "José Javier" "apellidos" => "Napal Lecumberri" ] 1 => array:2 [ "nombre" => "Paula" "apellidos" => "González Bores" ] 2 => array:2 [ "nombre" => "Alicia" "apellidos" => "Cuesta Marín" ] 3 => array:2 [ "nombre" => "Francisco Alejandro" "apellidos" => "Caballero Avendaño" ] 4 => array:2 [ "nombre" => "Jose Manuel" "apellidos" => "Olmos Martínez" ] 5 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "Hernández Hernández" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2529912321000218" "doi" => "10.1016/j.artere.2021.04.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912321000218?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916820300851?idApp=UINPBA00004N" "url" => "/02149168/0000003300000004/v1_202107150538/S0214916820300851/v1_202107150538/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2529912321000371" "issn" => "25299123" "doi" => "10.1016/j.artere.2021.07.004" "estado" => "S300" "fechaPublicacion" => "2021-07-01" "aid" => "557" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Clin Investig Arterioscler. 2021;33:175-83" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Evaluation of cardiometabolic profile in Health Professionals of Latin America" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "175" "paginaFinal" => "183" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Evaluación del perfil cardiometabólico en profesionales de salud de Latinoamérica" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1467 "Ancho" => 2157 "Tamanyo" => 116439 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Upper and lower body muscle strength by presence of hypertension and by sex.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ivetteh Gaibor-Santos, Jennifer Garay, Daniela A. Esmeral-Ordoñez, Diana Rueda-García, Daniel D. Cohen, Paul A. Camacho, Patricio Lopez-Jaramillo" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Ivetteh" "apellidos" => "Gaibor-Santos" ] 1 => array:2 [ "nombre" => "Jennifer" "apellidos" => "Garay" ] 2 => array:2 [ "nombre" => "Daniela A." "apellidos" => "Esmeral-Ordoñez" ] 3 => array:2 [ "nombre" => "Diana" "apellidos" => "Rueda-García" ] 4 => array:2 [ "nombre" => "Daniel D." "apellidos" => "Cohen" ] 5 => array:2 [ "nombre" => "Paul A." "apellidos" => "Camacho" ] 6 => array:2 [ "nombre" => "Patricio" "apellidos" => "Lopez-Jaramillo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0214916820301133" "doi" => "10.1016/j.arteri.2020.11.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0214916820301133?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912321000371?idApp=UINPBA00004N" "url" => "/25299123/0000003300000004/v1_202107270534/S2529912321000371/v1_202107270534/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Lipid profile and serum folate, vitamin B<span class="elsevierStyleInf">12</span> and homocysteine levels in patients with retinal vein occlusion" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "169" "paginaFinal" => "174" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "José Javier Napal Lecumberri, Paula González Bores, Alicia Cuesta Marín, Francisco Alejandro Caballero Avendaño, Jose Manuel Olmos Martínez, Jose Luis Hernández Hernández" "autores" => array:6 [ 0 => array:4 [ "nombre" => "José Javier" "apellidos" => "Napal Lecumberri" "email" => array:1 [ 0 => "josejavier.napal@scsalud.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Paula" "apellidos" => "González Bores" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Alicia" "apellidos" => "Cuesta Marín" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Francisco Alejandro" "apellidos" => "Caballero Avendaño" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:3 [ "nombre" => "Jose Manuel" "apellidos" => "Olmos Martínez" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 5 => array:3 [ "nombre" => "Jose Luis" "apellidos" => "Hernández Hernández" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Departamento de Medicina Interna, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Universidad de Cantabria, Santander, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Perfil lipídico y concentraciones séricas de ácido fólico, vitamina B12 y homocisteína en pacientes con obstrucción venosa retiniana" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Retinal vein occlusion (RVO) is the second cause of retinal impairment after diabetes mellitus and is therefore a major cause of sight loss.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> Depending on the degree of retinal occlusion it is classified as central or peripheral, with the latter being three times more prevalent.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> RVO is essentially related to major vascular risk factors (VRF), especially with high blood pressure (HBP) and as such RVO is considered to be a manifestation of atherosclerosis. Dyslipidaemia is a well defined RVO-associated VRF but the importance of lipid profile characteristics and hypolipemiant treatment in this disease are little known.<a class="elsevierStyleCrossRefs" href="#bib0020"><span class="elsevierStyleSup">4,5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">However, thrombophilia has been implicated in RVO pathogenesis, although with lower relevance than VRF. Here the importance of acquired thrombophilia stands out, defined by antiphospholipid syndrome and by hyperhomocysteineaemia.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6–8</span></a> The latter, related both to arthrosclerosis and thrombophilia, is usually the consequence of a deficiency of folate and to a lesser extent of vitamin B<span class="elsevierStyleInf">6</span> and B<span class="elsevierStyleInf">12</span>.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> However, the relationship between serum folate levels and vitamin B<span class="elsevierStyleInf">12</span> with the development of RVO<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10,11</span></a> has not been well defined and to our knowledge, there are no existing studies in this regard in Spain.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Based on the above, the aim of this study was to analyse the lipid profile and serum folate levels, vitamin B<span class="elsevierStyleInf">12</span> and homocysteine in patients with RVO and in a control group of the general population similar in age and sex.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Patients and methods</span><p id="par0020" class="elsevierStylePara elsevierViewall">All patients diagnosed with RVO by the Ophthalmology Unit from December 2008 to October 2019, who had been referred to the Internal Medicine Unit (Valdecilla cohort) were studied, based on clinical, fundoscopic and angiographic criteria, together with a control group of people selected consecutively from the annual follow-up check-up of a prospective cohort with a population base (Camargo cohort).<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12,13</span></a> The study took place in the Hospital Universitario Marqués de Valdecilla de Santander, a tertiary benchmark hospital serving a population of 350,000 inhabitants in Cantabria.</p><p id="par0025" class="elsevierStylePara elsevierViewall">All patients were assessed at the Internal Medicine practice within the first 10 days after diagnosis of RVO and in the initial consultation a baseline laboratory study was performed. In the patients with RVO, treatment of the VRF was optimised so that approximately 90% of our patients presented with an LDL cholesterol level <100<span class="elsevierStyleHsp" style=""></span>mg/dL and a BP level <140/80 one year after baseline visit. They were prescribed with vitamin B<span class="elsevierStyleInf">12</span>, folic acid or both if a deficiency in either was detected. In the case of a finding of hyperhomocysteineaemia (>15<span class="elsevierStyleHsp" style=""></span>μmol/L) with normal folic acid and vitamin B<span class="elsevierStyleInf">12</span>, levels, a daily tablet of 400<span class="elsevierStyleHsp" style=""></span>μg of folic acid and 2<span class="elsevierStyleHsp" style=""></span>μg of cyanocobalamin for at least three months was prescribed. We did this because we had observed, at the beginning of the study, that in 10 patients with hyperhomocysteineaemia and no evidence of a deficit of folic acid or vitamin B<span class="elsevierStyleInf">12</span>, the said treatment during three months corrected the hyperhomocysteineaemia en 80% of them.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Data collection</span><p id="par0030" class="elsevierStylePara elsevierViewall">Data collection was performed using a standardised questionnaire on a computerised database. The said questionnaire included demographic data (age and sex), clinical data and laboratory test results. The study was approved by the regional ethics committee and all subjects gave their informed consent.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Clinical variables</span><p id="par0035" class="elsevierStylePara elsevierViewall">The clinical variables recorded were: the differentiation between central or peripheral RVO (temporal or nasal), weight, height, tobacco habit, the presence of high blood pressure (blood pressure higher or equal to 140. 90<span class="elsevierStyleHsp" style=""></span>mmHg or receiving antihypertensive pharmacological treatment), diabetes mellitus, in keeping with the American Diabetes Association<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> criteria, dyslipidaemia (total cholesterol or triglycerides above 230<span class="elsevierStyleHsp" style=""></span>mg/dL and 150<span class="elsevierStyleHsp" style=""></span>mg/dL, in at least two determinations after 24<span class="elsevierStyleHsp" style=""></span>h fasting or receiving treatment with hypolipidaemic agents and treatment with statins.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Laboratory parameters</span><p id="par0040" class="elsevierStylePara elsevierViewall">Blood samples were taken from the anti-cubital vein between 8:00 and 10:00 a.m., with a period of 12<span class="elsevierStyleHsp" style=""></span>h fasting. The biochemical profile, was carried out in the biochemical laboratory of the same centre with an Advia® 2400 (Siemens) self-monitor and included the determination of: lipid profile (total cholesterol, cholesterol linked to high-density LDL lipoproteins, cholesterol linked to low-density lipoproteins (HDL), non-HDL cholesterol and triglycerides expressed in mg/dL). Several arthrogenic indexes (AI) were estimated: total/HDL cholesterol, LDL/HDL cholesterol, non-HDL/HDL cholesterol, triglycerides/HD.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Plasma levels of focal acid and vitamin B<span class="elsevierStyleInf">12</span> were determined through competitive immunoassay by direct chemiluminiscence (Advia Centaur by Bayer) with reference values of 2.6–20<span class="elsevierStyleHsp" style=""></span>ng/mL for folic acid and 211–911<span class="elsevierStyleHsp" style=""></span>pg/mL for vitamin B<span class="elsevierStyleInf">12</span>.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Serum homocysteine levels (μmol/L), were initially determined using a nephelometer (Siemens). From June 2012 the technique was changed and levels were determined through chemiluminiscence (Immulite 2000 Xpi; Siemens). Extraction carried out in the hospital was kept on ice, analysed before 3<span class="elsevierStyleHsp" style=""></span>h had passed and was considered high if they were above 15<span class="elsevierStyleHsp" style=""></span>μmol/L. To prevent variations attributable to the change of technique we excluded those made by nephelometer and only analysed the homocysteine made through chemiluminiscence, in patients and in controls. In most patients and controls the folic acid and vitamin B<span class="elsevierStyleInf">12</span> controls were determined from June 2012. Prior to this date they were only analysed in patients where there was clinical suspicion or through laboratory findings of said vitamin deficiency.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Statistical analysis</span><p id="par0055" class="elsevierStylePara elsevierViewall">Quantitative variables were expressed as a mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation or median and interquartile range and the qualitative variables as percentages. Quantitative variables were analysed using the Student's <span class="elsevierStyleItalic">t</span> test or the Mann–Whitney <span class="elsevierStyleItalic">U</span> test, depending on parameter distribution and qualitative variables with the Exact Fisher or <span class="elsevierStyleItalic">χ</span><span class="elsevierStyleSup">2</span> tests. To analyse the possible association of folate levels, vitamin B<span class="elsevierStyleInf">12</span> and hyperhomocysteineaemia with the presence of RVO, crude logistic regression models were constructed and adjusted by age, sex, body mass index (BMI), tobacco habit and the presence of classical FRCV (high blood pressure, diabetes and dyslipidaemia). Values of <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.05 were considered significant.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Results</span><p id="par0060" class="elsevierStylePara elsevierViewall">Three hundred and sixty eight patients with RVO and 325 controls were included in the study. RVO was peripheral in 254 cases (69%); 248 temporal and six nasal and was central in 114 (31%).</p><p id="par0065" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> contains comparison of demographic variables, serum lipid values (total cholesterol, LDL, HDL, no-HDL and triglycerides), arthrogenic indexes (AI) and the percentage of cases and controls who received treatment with statins.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0070" class="elsevierStylePara elsevierViewall">In patients and controls who did not receive treatment with statins, LDL figures were 134.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>32.6 vs. 125.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>26.9<span class="elsevierStyleHsp" style=""></span>mg/dL (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.04). Distribution of LDL, HDL cholesterol and triglycerides mg/dL in patients with RVO (<span class="elsevierStyleItalic">n</span>, %) was: LDL<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>116<span class="elsevierStyleHsp" style=""></span>mg/dL, 151 (41%); 89 cases LDL<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>100 (24.2%) and five patients had a LDL <55<span class="elsevierStyleHsp" style=""></span>mg/dL. HDL: men 149<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>40 (76.8%), women 115<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>50 (66.1%), 264 men or women<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>40 or 50, respectively (71.7%); triglycerides: 63 (17.1%)<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>150.</p><p id="par0075" class="elsevierStylePara elsevierViewall">Serum folate levels, vitamin B<span class="elsevierStyleInf">12</span>, homocysteine and percentage alterations of these parameters in cases and in controls are listed in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0080" class="elsevierStylePara elsevierViewall">The concentrations of folic acid (OR .94; 95% CI .89–.98; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>.011) and hyperhomocysteinaemia (OR 2.73; 95% CI 1.57–4.73; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.0001) are associated with the presence of RVO. Said values persist significantly after adjustment for age, sex, body mass index (BMI), tobacco habit and FRCV (high blood pressure, dyslipidaemia and diabetes mellitus). No association was found between the RVO and levels of vitamin B<span class="elsevierStyleInf">12</span> (OR .99; 95% CI .99–1.00; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>13).</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Discussion</span><p id="par0085" class="elsevierStylePara elsevierViewall">The Valdecilla cohort represents the prospective cohort of patients with RVO with a more prolonged follow-up of those reported in the literature (11 years at present).</p><p id="par0090" class="elsevierStylePara elsevierViewall">High blood pressure and diabetes mellitus were significantly more prevalent in our patients with RVO than in control groups, a fact that is in keeping with that published in the literature.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,7,16,17</span></a> We observed no differences in body mass index or in the prevalence of previous cardiovascular events in either group.</p><p id="par0095" class="elsevierStylePara elsevierViewall">In this study we have tried to respond to some often less well-known aspects of the disease such as its relationship with the lipid profile and with folic acid levels, vitamin B<span class="elsevierStyleInf">12</span> and homocysteine. We state that, in patients with RVO, HDL levels were significantly lower in the cases than in the controls. We also observed that the serum levels were significantly lower in the cases than in the controls. Serum levels of folic acid were also significantly lower and homocystine levels higher than in the population control group.</p><p id="par0100" class="elsevierStylePara elsevierViewall">Although serum levels of total cholesterol, LDL and triglycerides were higher in patients with RVO than in the controls, the differences were not significant. This lack of significance may be the consequence of the fact that a high percentage of patients and controls, higher in the cases of the latter, had already received treatment with hypolipidaemic agents, essentially with statins, at the time of the RVO. Thus when we analysed the patients who did not receive statins we observed there were significant differences in the LDL levels between cases and controls. However, the HDL, which was modified less with pharmacological treatments, was significantly lower in patients with RVO. HDL is a antiatherogenic lipoprotein particle which acts on the reverse transport of cholesterol and has beneficial vascular and antithrombotic effects.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> Also, in our patients with RVO the non HDL cholesterol and arthrogenic indexes such as that of Castelli (total cholesterol/HDL) or that related to LDL/HDL were significantly higher in patients with RVO. These indexes represent risk markers with a higher predictive value than that of isolated data since they combine two powerful components of vascular risk and subjects with elevation of these ratios have a higher cardiovascular risk based on greater imbalance between the cholesterol transported by the most arthrogenic lipoproteins and that of the lipoproteins with a protector effect. However, as reported by Oriole et al., <a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> analysing the anterior lipid profile to a vascular event, the parameters are not overly high so that the majority of our patients with RVO are grouped into the moderate risk lipid intervals (LDL <100–159, HDL >40/50 (men/women), triglycerides <150<span class="elsevierStyleHsp" style=""></span>mg/dL).</p><p id="par0105" class="elsevierStylePara elsevierViewall">Due to all of the above, and bearing in mind that atherosclerosis is the essential pillar in RVO pathogen, the lipid profile of the patients with the disease, with a lower level of HDL and a more unfavourable arthrogenic profile (higher arthrogenic indexes) and higher levels of triglycerides, are congruent with the unfavourable pathogenic role of dyslipidaemia in RVO. The aetiopathogenesis of RVO is multifactorial here. ÓMahoney et al.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a> suggest that this is the consequence of the dyslipidaemia in 20%, whilst high blood pressure accounts for it in 48%. Kim et al., <a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> in a study of a national cohort, stated there was an association between low HDL levels and the risk of developing an RVO. Newman-Casey et al.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a> also suggested that there was a reduction of HDL levels and the raising of serum triglyceride levels were risk factors in the development of peripheral RVO.</p><p id="par0110" class="elsevierStylePara elsevierViewall">Despite presenting with lower serum levels of folic acid and vitamin B<span class="elsevierStyleInf">12</span>, with the difference not being statistically significant in the latter, the deficiency of these vitamins, defined by the lower limit of normality of our laboratory, is infrequent in patients with RVO. This could be due to the fact that there is no defined cut-off point from which vascular risk increases, but it may increase progressively as the serum folate and vitamin B<span class="elsevierStyleInf">12</span><a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> levels drop.</p><p id="par0115" class="elsevierStylePara elsevierViewall">Studies which have analysed the association between vitamin B<span class="elsevierStyleInf">12</span> and folic acid levels and RVO revealed different results. Sofi et al., <a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> analysed 262 patients with RVO and the same number of controls and concluded that low vitamin B<span class="elsevierStyleInf">6</span> (OR .03; 95% CI 2.58–6.31; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.0001) and folic acid (OR 6.13; 95% CI 3.85–9.76, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>.0001) levels were associated with RVO and were separate from the standard VRF. However, these authors did not find any significant relationship between the RVO and vitamin B<span class="elsevierStyleInf">12</span> levels. Ferrazzi et al., <a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a> in a series of 64 patients with RVO observed vitamin B<span class="elsevierStyleInf">12</span> and folic acid levels dropping, although differences were not significant. Finally, Minniti et al., <a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> did find a significant association between low vitamin B<span class="elsevierStyleInf">12</span> levels and peripheral RVO, in 94 patients with RVO and 71 controls.</p><p id="par0120" class="elsevierStylePara elsevierViewall">Levels of folic acid, vitamin B<span class="elsevierStyleInf">12</span> and homocysteine, which depend on them, are the consequence of both dietary habits and the consumption of some drugs such as meformin or protone pump inhibitors.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> Regarding homocysteine, different studies have stated that their serum levels are higher in patients with RVO, regardless of sex, age and VRF.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,25–30</span></a> Hyperhomocysteinaemia is mainly associated with the deficiency of folate and to a lesser degree with deficiencies of vitamin B complex or systemic diseases such as kidney failure.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> Furthermore, this is an independent risk factor of artherosclerosis and has a multiplicative effect with other VRF, such as tobacco or high blood pressure and also a thrombophylic effect.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">Cattaneo et al.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a> and Rimm et al., <a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">32</span></a> have shown that folic acid and vitamin B<span class="elsevierStyleInf">12</span> are also separate risk factors of thrombotic vascular events, both arterial and venous. In this sense, several authors have suggested that the group B vitamins and folate play a role in the appearance of RVO, regardless of their influence on serum homocysteine levels.<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10,11,23</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">In population studies, Wright et al.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">33</span></a> observed that oral administration of folic acid reduced homocysteine by 25% and vitamin B<span class="elsevierStyleInf">12</span> by 7%. Treatment of hyperhomocysteinaemia and vitamin deficits may therefore revert this VRF, and its use was therefore recommended, in secondary prevention, in the treatment of cardiovascular diseases, including RVO.<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">32,33</span></a> However, for the moment, the efficacy of this therapeutic strategy in reducing vascular events has not yet been proven.</p><p id="par0135" class="elsevierStylePara elsevierViewall">Different authors observed a considerable increase in vascular events in patients with RVO, essentially strokes.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">34–36</span></a> In fact, Park et al.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">34</span></a> stated that this increase occurs from the first month of the RVO episode and for this reason, it is recommended that control of the standard VRF be controlled (high blood pressure, dyslipidaemia, diabetes mellitus, a tobacco habit) and they suggested controlling other risk factors (hyperhomocysteinaemia) to prevent new vascular events.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">30,37</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">This work presents with the limitation that the folic acid, vitamin B<span class="elsevierStyleInf">12</span> and homocysteine levels were only taken in half of the cases and in a third of three controls which suggests results should be interpreted with caution. Also, the presence of asymptomatic RVO cannot be fully ruled out in the control subjects, although this possibility is remote.</p><p id="par0145" class="elsevierStylePara elsevierViewall">To sum up, patients with RVO have serum levels of HDL and folic acid which are significantly lower and non HDL cholesterol levels and homocysteine levels which are higher than the population controls of similar age and sex. In these patients, apart from the lipid profile study, it may be useful to determine the levels of homocysteine, folic acid and vitamin B<span class="elsevierStyleInf">12</span>, in addition to considering treatment for their alteration. If this treatment is effective in the prevention of RVO recurrences or the development of new vascular events in these patients, this is something which may be worthwhile investigating in prospective studies designed to this effect.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Funding</span><p id="par0150" class="elsevierStylePara elsevierViewall">The study was financed party by funds from a grant from <span class="elsevierStyleGrantSponsor" id="gs0005">IS Carlos III</span> (<span class="elsevierStyleGrantNumber" refid="gs0005">PI15/00521</span>).</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conflict of interests</span><p id="par0155" class="elsevierStylePara elsevierViewall">The authors have no conflict of interests to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:15 [ 0 => array:3 [ "identificador" => "xres1554720" "titulo" => "Abstract" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objectives" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Patients and methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1403311" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1554721" "titulo" => "Resumen" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Antecedentes" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivos" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Pacientes y métodos" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1403310" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Patients and methods" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Data collection" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Clinical variables" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Laboratory parameters" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Statistical analysis" ] 10 => array:2 [ "identificador" => "sec0035" "titulo" => "Results" ] 11 => array:2 [ "identificador" => "sec0040" "titulo" => "Discussion" ] 12 => array:2 [ "identificador" => "sec0045" "titulo" => "Funding" ] 13 => array:2 [ "identificador" => "sec0050" "titulo" => "Conflict of interests" ] 14 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2020-05-13" "fechaAceptado" => "2020-07-13" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1403311" "palabras" => array:5 [ 0 => "Retinal vein occlusion" 1 => "Lipid profile" 2 => "Folate" 3 => "Vitamin B<span class="elsevierStyleInf">12</span>" 4 => "Homocysteine" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1403310" "palabras" => array:5 [ 0 => "Obstrucción venosa retiniana" 1 => "Perfil lipídico" 2 => "Ácido fólico" 3 => "Vitamina B<span class="elsevierStyleInf">12</span>" 4 => "Homocisteína" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Retinal vein occlusion (RVO) is mainly related with vascular risk factors (VRF).</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Objectives</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To analyze the lipid profile and serum folate, vitamin B<span class="elsevierStyleInf">12</span> and homocysteine levels, in patients with RVO and a population-based control group.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Patients and methods</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Case–control study. Patients with RVO were assessed during an 11-year period.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">We included 368 patients and 325 controls of similar age and sex. HDL cholesterol and folate levels were lower (52 [43–63]<span class="elsevierStyleHsp" style=""></span>mg/dL vs. 55 [46–66]<span class="elsevierStyleHsp" style=""></span>mg/dL; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.016 and 7 [5–10]<span class="elsevierStyleHsp" style=""></span>ng/mL vs. 9 [7–13]<span class="elsevierStyleHsp" style=""></span>ng/mL; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001, respectively) and non-HDL cholesterol and homocysteine levels higher (148.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>37.3<span class="elsevierStyleHsp" style=""></span>mg/dL vs. 142.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>34.5<span class="elsevierStyleHsp" style=""></span>mg/dL; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.03 and 13.4 [11.2–18.2]<span class="elsevierStyleHsp" style=""></span>μmol/L vs. 11.1 [9.0–14.4]<span class="elsevierStyleHsp" style=""></span>μmol/L; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001) in patients with RVO than controls. Although total cholesterol, LDL-<span class="elsevierStyleSmallCaps">C</span>, and triglyceride levels were higher and serum vitamin B<span class="elsevierStyleInf">12</span> levels were lower in RVO patients, these differences did not reach statistical significance.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Conclusions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">RVO-patients have lower serum HDL-C and folate levels and higher non-HDL-C and serum homocysteine levels than population-based controls of similar age and sex. In patients with RVO, apart from the lipid profile, determination of serum homocysteine, folate and vitamin B<span class="elsevierStyleInf">12</span> levels might be useful, as well as the treatment of their alterations.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Objectives" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Patients and methods" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Results" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Antecedentes</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">La obstrucción venosa retiniana (OVR) se relaciona fundamentalmente con los factores de riesgo vascular (FRV).</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Objetivos</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Analizar el perfil lipídico y las concentraciones séricas de ácido fólico, vitamina B<span class="elsevierStyleInf">12</span> y homocisteína, en pacientes con OVR y un grupo control poblacional.</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Pacientes y métodos</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Estudio de casos y controles. Los pacientes con OVR fueron estudiados a lo largo de un periodo de 11 años.</p></span> <span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Se incluyeron 368 casos y 325 controles de similar edad y sexo. En los pacientes con OVR respecto a los controles, las concentraciones de HDL colesterol y de ácido fólico fueron menores (52 [43-63]<span class="elsevierStyleHsp" style=""></span>mg/dL vs. 55 [46-66]; p<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,016 y 7 [5-10]<span class="elsevierStyleHsp" style=""></span>ng/mL vs. 9 [7-13]; p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,0001, respectivamente) y las de colesterol no HDL y de homocisteína fueron mayores (148,9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>37,3<span class="elsevierStyleHsp" style=""></span>mg/dL vs. 142,9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3; p<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,03 y 13,4 [11,2-18,2]<span class="elsevierStyleHsp" style=""></span>μmol/L vs. 11,1 [9,0-14,4]; p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,0001). Aunque las cifras de colesterol total, cLDL y triglicéridos fueron mayores y las concentraciones de vitamina B<span class="elsevierStyleInf">12</span> fueron menores en los pacientes con OVR, estas diferencias no fueron significativas.</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Los pacientes con OVR tienen concentraciones más bajas de colesterol HDL y de ácido fólico y cifras de colesterol no HDL y homocisteína más elevadas que los controles poblacionales de similar edad y sexo. En estos pacientes, además del perfil lipídico, podría ser útil la determinación de la homocisteína, el folato y la vitamina B<span class="elsevierStyleInf">12</span>, así como el tratamiento de sus alteraciones.</p></span>" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "abst0030" "titulo" => "Antecedentes" ] 1 => array:2 [ "identificador" => "abst0035" "titulo" => "Objetivos" ] 2 => array:2 [ "identificador" => "abst0040" "titulo" => "Pacientes y métodos" ] 3 => array:2 [ "identificador" => "abst0045" "titulo" => "Resultados" ] 4 => array:2 [ "identificador" => "abst0050" "titulo" => "Conclusiones" ] ] ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Please cite this article as: Napal Lecumberri JJ, González Bores P, Cuesta Marín A, Caballero Avendaño FA, Olmos Martínez JM, Hernández Hernández JL. Perfil lipídico y concentraciones séricas de ácido fólico, vitamina B12 y homocisteína en pacientes con obstrucción venosa retiniana. Clin Investig Arterioscler. 2021. <span class="elsevierStyleInterRef" id="intr0005" href="https://doi.org/10.1016/j.arteri.2020.07.001">https://doi.org/10.1016/j.arteri.2020.07.001</span></p>" ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">BMI: body mass index; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; RVO: retinal venal occlusion.</p><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Values expressed as mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD or median (interquartile range) or percentage.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">RVO<span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>368 \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Controls<span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>325 \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Age, years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">67.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>12.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">68.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>8.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.45 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Sex, man/woman \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">194/174 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">151/174 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.10 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">IMC, kg/m<span class="elsevierStyleSup">2</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">28.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">28.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.99 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Diabetes mellitus, <span class="elsevierStyleItalic">n</span> (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">89 (24.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">52 (16.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.008 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">High blood pressure, <span class="elsevierStyleItalic">n</span> (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">266 (72.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">173 (53.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cardiovascular events,<a class="elsevierStyleCrossRef" href="#tblfn0005">*</a><span class="elsevierStyleItalic">n</span> (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">49 (13.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">35 (10.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.31 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Total cholesterol, mg/dL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">203.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>39.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">200.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>37.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.21 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">LDL, mg/dL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">125.7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>34.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">120.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>31.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.06 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">HDL, mg/dL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">52 (43–63) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">55 (46–66) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.016 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Triglycerides, mg/dL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">113.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>59.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">104.5<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>37.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.05 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Non-HDL cholesterol, mg/dL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">148.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>37.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">142.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>34.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.03 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Total cholesterol/HDL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3.75 (3.20–4.42) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3.59 (3.03–4.19) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.003 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">LDL/HDL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.33 (1.80–2.77) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.19 (1.69–2.57) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Non-HDL/HDL cholesterol \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.75 (2.19–3.41) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.59 (2.04–3.19) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.003 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Triglycerides/HDL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.97 (1.29–2.82) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.82 (1.36–2.64) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.62 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Statins, <span class="elsevierStyleItalic">n</span> (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">110 (33.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">118 (36.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.067 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2664734.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "*" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Includes ischaemic cardiopathy, stroke and peripheral arterial disease.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Demographic data and standard lipid parameter levels and artherogenic indexes in patients with RVO and in controls.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Folic acid deficiency (<2.6<span class="elsevierStyleHsp" style=""></span>ng/mL); hyperhomocysteinaemia (>15<span class="elsevierStyleHsp" style=""></span>μmol/L); vitamin B<span class="elsevierStyleInf">12</span> deficiency (<211<span class="elsevierStyleHsp" style=""></span>pg/mL).</p><p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">Values expressed as median (interquartile range) or percentage.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="2" align="center" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">RVO</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " colspan="2" align="center" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Controls</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col"><span class="elsevierStyleItalic">p</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Value \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Value \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Folic acid, ng/mL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">187 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 (5–10) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">110 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9 (7–13) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Vitamin B<span class="elsevierStyleInf">12</span>, pg/mL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">191 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">374 (284–465) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">113 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">393 (320–484) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.09 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Homocysteine, μmol/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">170 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">13.4 (11.2–18.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">109 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11.1 (9–14.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Folic acid deficiency \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.5% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.9 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Vitamin B<span class="elsevierStyleInf">12</span> deficiency \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8.4% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6.2% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">.49 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Hyperhomocysteinaemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">72 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">42.4% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">23 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">21.3% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><.0001 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2664735.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Serum levels of folic acid, vitamin B<span class="elsevierStyleInf">12</span>, homocysteine and percentage of their changes in patients with retinal vein occlusion (RVO) and in the control group.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:37 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The prevalence of retinal vein occlusion pooled data from population studies from the United States, Europe Asia, and Australia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Rogers" 1 => "R.L. McIntosh" 2 => "N. Cheung" 3 => "L. Lim" 4 => "J.J. Wang" 5 => "P. Mitchell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ophtha.2009.07.017" "Revista" => array:6 [ "tituloSerie" => "Ophthalmology" "fecha" => "2010" "volumen" => "117" "paginaInicial" => "313" "paginaFinal" => "319" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20022117" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Kolar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "J Ophthalmol" "fecha" => "2014" "paginaInicial" => "724" "paginaFinal" => "780" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The burden of disease of retinal vein occlusion: review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Laouri" 1 => "E. Chen" 2 => "M. Looman" 3 => "M. Gallagher" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eye (Lond)" "fecha" => "2011" "volumen" => "25" "paginaInicial" => "981" "paginaFinal" => "988" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Retinal vein occlusion is associated with low blood high-density lipoprotein cholesterol: a nationwide cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J. Kim" 1 => "D.H. Lim" 2 => "K. Han" 3 => "S.W. Kang" 4 => "D.I. Ham" 5 => "S.J. Kim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ajo.2019.04.001" "Revista" => array:6 [ "tituloSerie" => "Am J Ophthalmol" "fecha" => "2019" "volumen" => "205" "paginaInicial" => "35" "paginaFinal" => "42" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30959001" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Statins in retinal disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Al-Janabi" 1 => "S. Lightman" 2 => "O. Tomkins-Netzer" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Eye (Lond)" "fecha" => "2018" "volumen" => "32" "paginaInicial" => "981" "paginaFinal" => "991" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Trombofilia y factores de riesgo vascular en la obstrucción venosa retiniana" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.J. Napal" 1 => "C. Sedano" 2 => "J. Cañal" 3 => "J.L. Hernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rce.2013.01.012" "Revista" => array:6 [ "tituloSerie" => "Rev Clin Esp" "fecha" => "2013" "volumen" => "213" "paginaInicial" => "229" "paginaFinal" => "234" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23566482" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Factores de riesgo vascular, fibrilación auricular no valvular y obstrucción venosa retiniana" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Lisa" 1 => "A. Córdoba" 2 => "J.L. Hernández" 3 => "R. Pérez" 4 => "J.J. Napal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rce.2016.10.013" "Revista" => array:6 [ "tituloSerie" => "Rev Clin Esp" "fecha" => "2017" "volumen" => "217" "paginaInicial" => "188" "paginaFinal" => "192" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27939441" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.C.H. Janssen" 1 => "M. den Heijer" 2 => "J.R.M. Cruysberg" 3 => "H. Wollersheim" 4 => "S.J.H. Bredie" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1160/TH04-11-0768" "Revista" => array:7 [ "tituloSerie" => "Thromb Haemost" "fecha" => "2005" "volumen" => "93" "paginaInicial" => "1021" "paginaFinal" => "1026" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15968383" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0266613812001398" "estado" => "S300" "issn" => "02666138" ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The controversy over homocysteine and cardiovascular risk" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "P.M. Ueland" 1 => "H. Refsum" 2 => "S.A. Beresford" 3 => "S.E. Vollset" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ajcn/72.2.324" "Revista" => array:7 [ "tituloSerie" => "Am J Clin Nutr" "fecha" => "2000" "volumen" => "72" "paginaInicial" => "324" "paginaFinal" => "332" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10919921" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0140673615010247" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Sofi" 1 => "R. Marcucci" 2 => "P. Bolli" 3 => "B. Giambene" 4 => "A. Sodi" 5 => "S. Fedi" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Atheroesclerosis" "fecha" => "2008" "volumen" => "198" "paginaInicial" => "223" "paginaFinal" => "227" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma homocysteine in patients with retinal vein occlusion" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Minniti" 1 => "M.G. Calevo" 2 => "A. Giannattasio" 3 => "P. Camicione" 4 => "U. Armani" 5 => "R. Lorini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5301/ejo.5000426" "Revista" => array:6 [ "tituloSerie" => "Eur J Ophthalmol" "fecha" => "2014" "volumen" => "24" "paginaInicial" => "735" "paginaFinal" => "743" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24519513" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Influence of vitamin D status on the effect of statins on bone mineral density and bone turnover markers in postmenopausal women" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.L. Hernández" 1 => "J.M. Olmos" 2 => "G. Romaña" 3 => "J. Llorca" 4 => "J. Martínez" 5 => "J. Castillo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/jc.2014-1102" "Revista" => array:6 [ "tituloSerie" => "J Clin Endocrinol Metab" "fecha" => "2014" "volumen" => "99" "paginaInicial" => "3304" "paginaFinal" => "3309" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24878047" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.M. Olmos" 1 => "J.L. Hernández" 2 => "P. García-Velasco" 3 => "J. Martínez" 4 => "J. Llorca" 5 => "J. González-Macías" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00198-015-3219-6" "Revista" => array:6 [ "tituloSerie" => "Osteoporos Int" "fecha" => "2016" "volumen" => "27" "paginaInicial" => "105" "paginaFinal" => "113" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26134682" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Standards of medical care in diabetes 2011" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "American Diabetes Association" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc11-S011" "Revista" => array:6 [ "tituloSerie" => "Diabetes Care" "fecha" => "2011" "volumen" => "34" "paginaInicial" => "S11" "paginaFinal" => "S61" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21193625" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Documento de consenso sobre el manejo de la dislipemia aterogénica de la Sociedad Española de Arterioesclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.F. Ascaso" 1 => "J. Millán" 2 => "A. Hernández-Mijares" 3 => "M. Blasco" 4 => "A. Brea" 5 => "Á. Díaz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Investig Arterioescler" "fecha" => "2017" "volumen" => "29" "paginaInicial" => "86" "paginaFinal" => "91" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "La hipertensión arterial y el score de Framingham de riesgo vascular en la obstrucción venosa retiniana" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Lisa" 1 => "M. Vieitez" 2 => "Z. Salmón" 3 => "S. Qiu" 4 => "J.L. Hernández" 5 => "J.J. Napal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.hipert.2018.12.004" "Revista" => array:6 [ "tituloSerie" => "Hipertens Riesgo Vasc" "fecha" => "2019" "volumen" => "36" "paginaInicial" => "193" "paginaFinal" => "198" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30837159" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of coagulation disorders in patients with retinal vein occlusion" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.J. Napal" 1 => "S. Neila" 2 => "R. Pérez-Montes" 3 => "I. Sierra" 4 => "S. Ruiz" 5 => "J.L. Hernández" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/qjmed/hcv088" "Revista" => array:6 [ "tituloSerie" => "QJM" "fecha" => "2016" "volumen" => "109" "paginaInicial" => "97" "paginaFinal" => "102" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25972353" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anthropometric and dietary determinants of blood levels of HDL cholesterol in a population-based study. The REGICOR study. Researchers of the REGICOR study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Sentí" 1 => "R. Masià" 2 => "A. Pena" 3 => "R. Elosua" 4 => "C. Aubó" 5 => "M. Bosch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0300-8932(98)74851-1" "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "1998" "volumen" => "51" "paginaInicial" => "979" "paginaFinal" => "987" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9927849" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Control lipídico y factores de riesgo asociados, antes del padecimiento del primer evento cardiovascular" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P.A. Oriol" 1 => "T. Badía" 2 => "A. Romaguera" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Investig Arterioescler" "fecha" => "2019" "volumen" => "31" "paginaInicial" => "141" "paginaFinal" => "151" ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Retinal vein occlusion and traditional risk factors for atherosclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P.R.A. ÓMahoney" 1 => "D.T. Wong" 2 => "J.G. Ray" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archopht.126.5.692" "Revista" => array:6 [ "tituloSerie" => "Arch Ophthalmol" "fecha" => "2008" "volumen" => "126" "paginaInicial" => "692" "paginaFinal" => "699" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18474782" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P.A. Newman-Casey" 1 => "M. Stem" 2 => "N. Talwar" 3 => "D.C. Musch" 4 => "C.G. Besirli" 5 => "J.D. Stein" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Ophthalmology" "fecha" => "2014" "volumen" => "121" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.J. Boushey" 1 => "S.A. Beresford" 2 => "G.S. Omenn" 3 => "A.G. Motulsky" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.1995.03530130055028" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1995" "volumen" => "274" "paginaInicial" => "1049" "paginaFinal" => "1057" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7563456" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B12 in patients with retinal vein occlusion" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Ferrazzi" 1 => "P. Di Micco" 2 => "I. Qualglia" 3 => "L.S. Rossi" 4 => "A.G. Bellatorre" 5 => "G. Gaspari" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1477-9560-3-3" "Revista" => array:6 [ "tituloSerie" => "Thromb J" "fecha" => "2005" "volumen" => "3" "paginaInicial" => "3" "paginaFinal" => "13" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15796773" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vitamin B12 deficiency in metformin-treated type-2 diabetes patients, prevalence and association with peripheral neuropathy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.A. Ahmed" 1 => "G. Muntingh" 2 => "P. Rheeder" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s40360-016-0088-3" "Revista" => array:4 [ "tituloSerie" => "BMC Phamacol Toxicol" "fecha" => "2016" "volumen" => "17" "paginaInicial" => "44" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors associated with retinal vein occlusion" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F. Martínez" 1 => "E. Furió" 2 => "M.J. Fabiá" 3 => "A.V. Pérez" 4 => "V. González-Albert" 5 => "G. Rojo-Martínez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ijcp.12390" "Revista" => array:6 [ "tituloSerie" => "Int J Clin Pract" "fecha" => "2014" "volumen" => "68" "paginaInicial" => "871" "paginaFinal" => "881" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24548738" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S.J. McGimpsey" 1 => "J.V. Woodside" 2 => "C. Cardwell" 3 => "M. Cahill" 4 => "U. Chakravarthy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ophtha.2009.02.033" "Revista" => array:6 [ "tituloSerie" => "Ophthalmology" "fecha" => "2009" "volumen" => "116" "paginaInicial" => "1778" "paginaFinal" => "1787" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19729099" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hyperhomocystinemia and C677T MTHFR genotype in patients with retinal vein thrombosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Sottilotta" 1 => "S.M. Siboni" 2 => "C. Latella" 3 => "V. Oriana" 4 => "E. Romeo" 5 => "R. Santoro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1076029609348644" "Revista" => array:6 [ "tituloSerie" => "Clin Appl Thromb Hemost" "fecha" => "2010" "volumen" => "16" "paginaInicial" => "549" "paginaFinal" => "553" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19825913" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D. Li" 1 => "M. Zhou" 2 => "X. Peng" 3 => "H. Sun" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "BMC Ophtalmol" "fecha" => "2014" "volumen" => "14" "paginaInicial" => "147" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I.M. Graham" 1 => "L.E. Daly" 2 => "H.M. Refsum" 3 => "K. Robinson" 4 => "L.E. Brattström" 5 => "P.M. Ueland" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.1997.03540460039030" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1997" "volumen" => "277" "paginaInicial" => "1775" "paginaFinal" => "1781" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9178790" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum homocysteine levels in patients with retinal vein occlusion in a Spanish population" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.L. Hernández" 1 => "M. Lisa" 2 => "J.J. Napal" 3 => "A. Córdoba" 4 => "J.M. Olmos" 5 => "S. Ruiz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Ophthalmic Res Ocular Care" "fecha" => "2017" "volumen" => "1" "paginaInicial" => "12" "paginaFinal" => "17" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Cattaneo" 1 => "R. Lombardi" 2 => "A. Lecchi" 3 => "P. Bucciarelli" 4 => "P.M. Mannucci" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Circulation" "fecha" => "2001" "volumen" => "20" "paginaInicial" => "2442" "paginaFinal" => "2446" ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.B. Rimm" 1 => "W.C. Willett" 2 => "F.B. Hu" 3 => "L. Sampson" 4 => "G.A. Colditz" 5 => "J.E. Manson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.279.5.359" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1998" "volumen" => "279" "paginaInicial" => "359" "paginaFinal" => "364" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9459468" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Homocysteine, folates, and eye" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.D. Wright" 1 => "N. Martin" 2 => "P.M. Dodson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.eye.6703061" "Revista" => array:6 [ "tituloSerie" => "Eye" "fecha" => "2008" "volumen" => "22" "paginaInicial" => "989" "paginaFinal" => "993" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18064053" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of stroke in retinal vein occlusion" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S.J. Park" 1 => "N.K. Choi" 2 => "B.R. Yang" 3 => "K.H. Park" 4 => "S.J. Woo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1212/WNL.0000000000002085" "Revista" => array:6 [ "tituloSerie" => "Neurology" "fecha" => "2015" "volumen" => "85" "paginaInicial" => "1578" "paginaFinal" => "1584" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26453647" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A longitudinal analysis of risk factors associated with central retinal vein occlusion" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.S. Stem" 1 => "N. Talwar" 2 => "G.M. Comer" 3 => "J.D. Stein" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ophtha.2012.07.080" "Revista" => array:6 [ "tituloSerie" => "Ophthalmology" "fecha" => "2013" "volumen" => "120" "paginaInicial" => "362" "paginaFinal" => "370" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23177364" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Retinal vein occlusion and risk of cerebrovascular disease and myocardial infarction: a meta-analysis of cohort studies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C. Zhong" 1 => "S. You" 2 => "X. Zhong" 3 => "G.C. Chen" 4 => "T. Xu" 5 => "Y. Zhang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.atherosclerosis.2016.02.024" "Revista" => array:7 [ "tituloSerie" => "Atherosclerosis" "fecha" => "2016" "volumen" => "247" "paginaInicial" => "170" "paginaFinal" => "176" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26922716" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0022347616300543" "estado" => "S300" "issn" => "00223476" ] ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Retinal vein thrombosis: the Internist's role in the etiologic and therapeutic management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Garcia-Horton" 1 => "F. Al-Ani" 2 => "A. Lazo-Langner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.thromres.2017.03.015" "Revista" => array:5 [ "tituloSerie" => "Thromb Res" "fecha" => "2016" "paginaInicial" => "118" "paginaFinal" => "124" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28318571" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/25299123/0000003300000004/v1_202107270534/S2529912321000218/v1_202107270534/en/main.assets" "Apartado" => array:4 [ "identificador" => "64744" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Originals" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/25299123/0000003300000004/v1_202107270534/S2529912321000218/v1_202107270534/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529912321000218?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 2 | 0 | 2 |
2024 October | 7 | 15 | 22 |
2024 September | 33 | 22 | 55 |
2024 August | 26 | 31 | 57 |
2024 July | 11 | 23 | 34 |
2024 June | 17 | 7 | 24 |
2024 May | 24 | 17 | 41 |
2024 April | 15 | 12 | 27 |
2024 March | 125 | 13 | 138 |
2024 February | 51 | 15 | 66 |
2024 January | 36 | 24 | 60 |
2023 December | 54 | 29 | 83 |
2023 November | 66 | 23 | 89 |
2023 October | 35 | 29 | 64 |
2023 September | 17 | 16 | 33 |
2023 August | 23 | 26 | 49 |
2023 July | 18 | 28 | 46 |
2023 June | 13 | 14 | 27 |
2023 May | 20 | 7 | 27 |
2023 April | 12 | 5 | 17 |
2023 March | 15 | 2 | 17 |
2023 February | 10 | 4 | 14 |
2023 January | 16 | 4 | 20 |
2022 December | 17 | 4 | 21 |
2022 November | 13 | 5 | 18 |
2022 October | 15 | 4 | 19 |
2022 September | 10 | 9 | 19 |
2022 August | 16 | 10 | 26 |
2022 July | 15 | 6 | 21 |